Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:45 PM
Ignite Modification Date:
2025-12-24 @ 11:45 PM
NCT ID:
NCT00144651
Eligibility Criteria:
Inclusion Criteria:
* Patients administered MRA more than 2 times in preceding study, MRA009JP, and evaluated the efficacy and the safety.
* Patients confirmed to have shown the safety in the preceding study.
Exclusion Criteria:
* Patients with Class IV Steinbrocker functional activity at evaluation within 4 weeks before treatment with the study drug
* Patients who received any of the following treatments between the start of preceding study and the registration of this study.
1. Plasma exchange therapy
2. Surgical treatment (e.g., operation)
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
20 Years
Study:
NCT00144651
Study Brief:
Protocol Section:
NCT00144651